Inosan_Biopharma_IMG_2020_Juan_Silanes
View from the Top
Juan Silanes
CEO
Inosan Biopharma
Inosan Biopharma creates unique healthcare treatments to treat neglected health complications in developing regions.
President López Obrador with winners of the so-called presidental plane raffle.
News Article
Highlights: AMLO says officials linked to investigation against former Sedena head will be suspended. Claims ‘mafias’ are behind fake flu drugs…
Influenza Season Meets Covid-19
Weekly Roundups
COVID-19 is far from being over but seven months facing the pandemic have make the sector resilient.
The Role of Authorized Third Parties in the 4T
News Article
Where do authorized third parties stand after the numerous changes and pronunciations regarding COFEPRIS?
President López Obrador and Chancellor Marcelo Ebrard listen to CanSino CEO Yu Xuefeng during his participation on a remote video call.
News Article
Highlights: Ebrard details agreements with AstraZeneca, Pfizer and CanSino. Herrera reports on expenditure. AMLO alleges plot on cancer drugs…
María Luisa Gutiérrez CEO of Medisi
View from the Top
María Luisa Gutiérrez
CEO
Medisi
An evolving regulatory environment challenges the medical devices industry. Medisi sees this as an opportunity, rather than a disadvantage.
Melissa Rosales
Expert Contributor
Melissa Rosales
Director General
RM Pharma
https://www.linkedin.com/in/melissa-rosales-cort%C3%A9s-5a738389/
https://twitter.com/rmpharmas
https://www.rmpharma.mx/nosotros
Clinical trials are important for discovering new treatments, as well as new ways to detect, diagnose and reduce the chance of developing the disease.
Healthcare Budget Grows 9.1 Percent
Analysis
Is this increase enough? What other alternatives or initiatives could benefit the sector and help achieve universal coverage?
Counterfeit Drugs
News Article
Product piracy is no longer reserved for luxury product. Many other sectors have been hit, including pharma.
Subscribe to COFEPRIS